(Q72191743)
Statements
Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation (English)
Johnson BD
McCabe C
Hanke CA